BURLINGTON, Ontario–(BUSINESS WIRE)—- $ANRG #ANRG–Anaergia (TSX: ANRG; OTCQX:ANRGF) reports positive Adjusted EBITDA, 61% revenue growth and Revenue Backlog up 149% in fiscal 2025.